BTG Wins FDA Clearance for LC Bead LUMI

BTG has won FDA 510(k) clearance for its LC Bead LUMI, a radiopaque embolic bead for the embolization of hypervascular tumors and arteriovenous malformations.

Featuring radiopacity technology, the LC Bead LUMI enables the visualization of beads during an embolization procedure.

According to the company, the bead could offer interventional radiologists more control, enabling more precise evaluation of the completeness of tumor treatment. — Michael Cipriano